|
|
Targeted Immunotherapy in a Nonhuman Primate Model of Alzheimers Disease |
| 3R24OD028257-03S1 |
|
OD |
2022 |
|
|
TRiP resources for modeling human disease |
| 3R24OD030002-03S1 |
|
OD |
2022 |
|
|
HTORR/ NIMH ASD and Control Brain Recovery Project |
| 3U42OD011158-31S4 |
|
OD |
2022 |
|
|
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM |
| 3UH3OD023347-07S1 |
|
OD |
2022 |
|
|
Pre-adolescent and Late-adolescent Follow-up of the CHARGE Study Children |
| 3UH3OD023365-07S1 |
|
OD |
2022 |
|
|
Illuminating GABAergic Signaling in Neurodevelopmental Disorders |
| 5DP5OD026428-05 |
|
OD |
2022 |
|
|
Patient-centered rehabilitation and dexterous assistive devices for stroke patients using bionic exoskeletons controlled by non-invasive electromyography |
| 5DP5OD029571-03 |
|
OD |
2022 |
|
|
Revealing tissue microstructure in the brain gray matter in Alzheimers disease using in vivo high-gradient diffusion MRI |
| 5DP5OD031854-02 |
|
OD |
2022 |
|
|
Sex differences and metabolic responses to chronic stress |
| 5F30OD032120-02 |
|
OD |
2022 |
|
|
Collagen XVII unmasking in Parkinsons disease and scratching |
| 5R21OD030057-02 |
|
OD |
2022 |